Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies
Similar Posts
Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling – FDA Safety Communication
FDA is aware of serious complications reported with certain uses of radiofrequency microneedling devices; asks for reports of injuries related these devicesNatural MiracleZEN Platinum 70000 may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Natural MiracleZEN Platinum 70000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Clinical Outcome Assessments (COA) Qualification Program Submissions
Clinical Outcome Assessments (COA) Qualification Program SubmissionsGDUFA III Reauthorization
Generic drug user fees make it possible for FDA and industry to continue to ensure that the American public has access to safe, effective and high-quality generic drugs. The implementation of the Generic Drug User Fee Amendments (GDUFA) encompasses a wide range of activities that fall within the scoEarly Alert: Cardiac Cannula Issue from Medtronic
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramLil’ Turtles Issues a Voluntary Recall Due to Undeclared Milk Allergen
Baltic, OH (Dec. 4, 2025) – Lil’ Turtles is recalling all lots of its Grandma Belle’s Tomato Basil Soup for misbranding due to the milk allergen not being declared on the label. The Grandma Belle’s Tomato Basil Soup was packaged in 17 oz glass jars.